These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22990084)

  • 21. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5.
    Pitman R; Fisman D; Zaric GS; Postma M; Kretzschmar M; Edmunds J; Brisson M;
    Med Decis Making; 2012; 32(5):712-21. PubMed ID: 22990086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.
    Mauskopf JA; Sullivan SD; Annemans L; Caro J; Mullins CD; Nuijten M; Orlewska E; Watkins J; Trueman P
    Value Health; 2007; 10(5):336-47. PubMed ID: 17888098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report.
    Drummond M; Barbieri M; Cook J; Glick HA; Lis J; Malik F; Reed SD; Rutten F; Sculpher M; Severens J
    Value Health; 2009 Jun; 12(4):409-18. PubMed ID: 19900249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applying dynamic simulation modeling methods in health care delivery research-the SIMULATE checklist: report of the ISPOR simulation modeling emerging good practices task force.
    Marshall DA; Burgos-Liz L; IJzerman MJ; Osgood ND; Padula WV; Higashi MK; Wong PK; Pasupathy KS; Crown W
    Value Health; 2015 Jan; 18(1):5-16. PubMed ID: 25595229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
    Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
    Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Decision analysis in radiology using Markov models].
    Golder W
    Rofo; 2000 Jan; 172(1):80-5. PubMed ID: 10719468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Healthy, Sick, Dead - An Educational Blueprint to State Transition Disease Modelling.
    Schramm W; Rickmann J; Sailer F
    Stud Health Technol Inform; 2017; 238():223-226. PubMed ID: 28679929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis alongside clinical trials II-An ISPOR Good Research Practices Task Force report.
    Ramsey SD; Willke RJ; Glick H; Reed SD; Augustovski F; Jonsson B; Briggs A; Sullivan SD
    Value Health; 2015 Mar; 18(2):161-72. PubMed ID: 25773551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.
    Husereau D; Drummond M; Petrou S; Carswell C; Moher D; Greenberg D; Augustovski F; Briggs AH; Mauskopf J; Loder E;
    Value Health; 2013; 16(2):231-50. PubMed ID: 23538175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple Criteria Decision Analysis for Health Care Decision Making--An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force.
    Thokala P; Devlin N; Marsh K; Baltussen R; Boysen M; Kalo Z; Longrenn T; Mussen F; Peacock S; Watkins J; Ijzerman M
    Value Health; 2016 Jan; 19(1):1-13. PubMed ID: 26797229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III.
    Johnson ML; Crown W; Martin BC; Dormuth CR; Siebert U
    Value Health; 2009; 12(8):1062-73. PubMed ID: 19793071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Verification of Decision-Analytic Models for Health Economic Evaluations: An Overview.
    Dasbach EJ; Elbasha EH
    Pharmacoeconomics; 2017 Jul; 35(7):673-683. PubMed ID: 28456972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamic medication adherence modeling in primary prevention of cardiovascular disease: a Markov microsimulation methods application.
    Slejko JF; Sullivan PW; Anderson HD; Ho PM; Nair KV; Campbell JD
    Value Health; 2014 Sep; 17(6):725-31. PubMed ID: 25236996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic assessment of decision-analytic models for chronic myeloid leukemia.
    Rochau U; Schwarzer R; Jahn B; Sroczynski G; Kluibenschaedl M; Wolf D; Radich J; Brixner D; Gastl G; Siebert U
    Appl Health Econ Health Policy; 2014 Apr; 12(2):103-15. PubMed ID: 24385259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report.
    Jaime Caro J; Eddy DM; Kan H; Kaltz C; Patel B; Eldessouki R; Briggs AH;
    Value Health; 2014 Mar; 17(2):174-82. PubMed ID: 24636375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding noise to Markov cohort state-transition model in decision modeling and cost-effectiveness analysis.
    Iskandar R
    Stat Med; 2020 May; 39(10):1529-1540. PubMed ID: 32017193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7.
    Eddy DM; Hollingworth W; Caro JJ; Tsevat J; McDonald KM; Wong JB;
    Med Decis Making; 2012; 32(5):733-43. PubMed ID: 22990088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decision-analytic modeling studies: An overview for clinicians using multiple myeloma as an example.
    Rochau U; Jahn B; Qerimi V; Burger EA; Kurzthaler C; Kluibenschaedl M; Willenbacher E; Gastl G; Willenbacher W; Siebert U
    Crit Rev Oncol Hematol; 2015 May; 94(2):164-78. PubMed ID: 25620327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5.
    Pitman R; Fisman D; Zaric GS; Postma M; Kretzschmar M; Edmunds J; Brisson M;
    Value Health; 2012; 15(6):828-34. PubMed ID: 22999132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Markov models in medical decision making: a practical guide.
    Sonnenberg FA; Beck JR
    Med Decis Making; 1993; 13(4):322-38. PubMed ID: 8246705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.